'Gut Health'

9 September 2017, Cavendish Conference Centre, London

Expert speakers

Course gluten-free lunch

Exhibitors

CPD hours

Nigel Plummer | Ben Brown | Kiran Krishnan

*This conference is now completely sold out. To add yourself to the waiting list, click here.*

9.15 – 9.45
Registration

Enjoy teas, herbal teas, coffee, and seasonal cut fruit during registration.

9.45 – 11.00
Ben Brown

Does irritable bowel syndrome exist? Nutritional, metabolic and digestive assessment renders diagnosis less relevant and improves treatment.

Irritable bowel syndrome (IBS) is an umbrella diagnosis made using symptom-based criteria that does not help to direct treatment. Consequently, people with IBS are often poorly managed and symptoms remain a burden for approximately 20% of people. An alternative view is that IBS does not exist as a clinical entity but is in fact a clinical presentation of several distinct, independent and often treatable underlying conditions.

Clinical management then requires an approach based on our evolving knowledge of the underlying multi-factorial origins of “IBS-like” symptoms unique to each individual. Accessible and cost-effective nutritional, metabolic and digestive assessments can help identify the cause of symptoms and direct and personalise treatment.

This talk explores the underlying causes of digestive symptoms as well as the clinical assessment tools that can be used to identify them. We also look at how assessment can be used to inform personalised dietary, lifestyle and nutritional interventions that improve physiological function, restore gastrointestinal health and resolve symptoms.

About Ben Brown

Ben is a naturopath, science writer and speaker. He is on the advisory board and a lecturer at the UK College of Nutrition and Health (BCNH) and guest lectures at various educational institutions and in university settings. Ben regularly speaks at major conferences and delivers courses on integrative medicine for health care professionals.

Throughout his career Ben has had extensive clinical experience, maintaining a private practice in Australia and in London, England. He has also worked in nutraceutical research and development for a number of leading global companies and served on advisory boards for integrative medical clinics and wellness services.

An established science writer, Ben frequently contributes to peer reviewed scientific journals, is Associate Editor for CAM Magazine the UK’s primary journal for integrative health professionals and author of The Digestive Health Solution.

Ben’s tertiary qualifications are in in naturopathic medicine, a distinct profession of primary health care that integrates conventional clinical medicine and diagnostics with functional pathology and a broad range of natural therapies including therapeutic lifestyle change, mind-body therapies, nutritional and herbal medicines.

11.00 – 11.30
Refreshments

A short break for delegates to enjoy some refreshments and to network with peers and exhibitors.

11.30 – 12.45
Kiran Krishnan

The spectacular role of the human microbiome in preventing post-prandial endotoxemia, the number one cause of mortality worldwide.

Post-Prandial Endotoxemia (systemic toxicity because of diet) triggers oxidative stress which, along with changes in the immune system, create conditions that lead to gut permeability and chronic, low-grade inflammation. An often-overlooked role of the microbiome is to prevent post-prandial endotoxemia and the inflammatory devastation that follows. This lecture will illustrate the danger of having post-prandial endotoxemia (PPE) and why this condition is being called the number one cause of mortality worldwide. PPE sets up the body for virtually every chronic disease known in the western world. This condition is caused by eating high-calorie and high-fat meals and a failure of the microbiome to protect its host from this response. You simply cannot completely correct any chronic condition without addressing post-prandial endotoxemia first.

Topic Overview:

  • The role of the microbiome in controlling the immune system, the brain, the endocrine system. and nutrient production – the critical cross-talk between microbe and host.
  • Understanding post-prandial endotoxemia (PPE) and its resulting effects on the human body.
  • Strategies for probiotic therapy that can impact PPE.
  • Results of a clinically validated trial on leaky gut.
  • How to shift and balance the microbiota population.
  • The role of transient, commensal spore-based probiotics in bacteriotherapy to treat PPE.
About Kiran Krishnan

Kiran Krishnan is a Research Microbiologist and has been involved in the dietary supplement and nutrition market for the past 16 years. He comes from a strict research background having spent several years with hands-on R&D in the fields of molecular medicine and microbiology at the University of Iowa. Mr. Krishnan earned his Bachelor of Science degrees in Microbiology at the University of Iowa; his undergraduate education was followed up with post graduate research in Molecular Biology and Virology. He left University research to take a position as the U.S. Business Development and Product Development lead for Amano Enzyme, USA. Amano is one of the world’s largest suppliers of therapeutic enzymes used in the dietary supplement and pharmaceutical industries in North America.

Kiran also established a Clinical Research Organization where he designed and conducted over a dozen human clinical trials in human nutrition. Kiran is also a co-founder and partner in Nu Science Trading, LLC.; a nutritional technology development, research and marketing company in the U.S. Dietary Supplement and Medical Food markets. Most recently, Kiran is acting as the Chief Scientific Officer at Physician’s Exclusive, LLC. and Microbiome Labs. He is a frequent lecturer on the Human Microbiome at Medical and Nutrition Conferences. He conducts regular Microbiome webinars and has been a guest speaker on numerous Health Summits as a microbiome expert. He is currently involved with 9 clinical trials and 4 lab studies.

Kiran brings his extensive knowledge and practical application of the latest science on the human microbiome as it relates to health and wellness.

12.45 – 14.00
Lunch

Enjoy a three course gluten-free buffet lunch, with time to network with peers and exhibitors.

14.00 – 15.00
Dr Nigel Plummer, PhD

The Interaction of Intestinal Physiology with the Microbiome: Understanding this Cross-Talk has Implications for Diseases from Allergy to Alzheimer’s

The intestinal tract is now known to be a major centre of immune, endocrine and neural function, as well as its established role in digestion, absorption and substance elimination. Similarly, we now understand the pervasive importance of our microbiome in facilitating and influencing this functionality.

This lecture will focus on concisely describing the characteristics of the microbiome, how it is established and how it functions by communicating with our intestinal physiology and pathology, thereby influencing diseases ranging from allergy, through to autoimmune disease, metabolic disease and those affecting the gut-brain axis.

Secondly, the critical role that adverse and beneficial manipulators of the microbiome, such as antibiotics and probiotics, have in promoting or mitigating disease risk will be thoroughly explored. Dr Plummer will provide evidence-based examples and guidelines on how to use these tools to positive effect in everyday practice.

About Nigel Plummer

A microbial physiologist, Dr Nigel Plummer, PhD is the researcher behind the highly thought-of LAB4 probiotic strains, and is in huge demand internationally.

Dr Plummer received his doctorate in microbial physiology from the University of Surrey, UK and has since built his career specialising in antibiotic research and development.  His research on the use of normal flora in the prevention and treatment of genito-urinary candidiasis has won numerous awards.

Dr Plummer continues his solid commitment to research specialising in probiotics, natural antimicrobials and fish oils in collaboration with research institutes and universities within the UK, including Addenbrooke’s Hospital, Cambridge, the University of Swansea Medical School, Cardiff University and the University of Sheffield Medical School.

15.00 – 15.30
Refreshments

A short break in the presentation for delegates to enjoy some refreshments.

15.30 – 16.30
Dr Nigel Plummer, PhD

The Interaction of Intestinal Physiology with the Microbiome: Understanding this Cross-Talk has Implications for Diseases from Allergy to Alzheimer’s

The intestinal tract is now known to be a major centre of immune, endocrine and neural function, as well as its established role in digestion, absorption and substance elimination. Similarly, we now understand the pervasive importance of our microbiome in facilitating and influencing this functionality.

This lecture will focus on concisely describing the characteristics of the microbiome, how it is established and how it functions by communicating with our intestinal physiology and pathology, thereby influencing diseases ranging from allergy, through to autoimmune disease, metabolic disease and those affecting the gut-brain axis.

Secondly, the critical role that adverse and beneficial manipulators of the microbiome, such as antibiotics and probiotics, have in promoting or mitigating disease risk will be thoroughly explored. Dr Plummer will provide evidence-based examples and guidelines on how to use these tools to positive effect in everyday practice.

About Nigel Plummer

A microbial physiologist, Dr Nigel Plummer, PhD is the researcher behind the highly thought-of LAB4 probiotic strains, and is in huge demand internationally.

Dr Plummer received his doctorate in microbial physiology from the University of Surrey, UK and has since built his career specialising in antibiotic research and development. His research on the use of normal flora in the prevention and treatment of genito-urinary candidiasis has won numerous awards.

Dr Plummer continues his solid commitment to research specialising in probiotics, natural antimicrobials and fish oils in collaboration with research institutes and universities within the UK, including Addenbrooke’s Hospital, Cambridge, the University of Swansea Medical School, Cardiff University and the University of Sheffield Medical School.

16.30
Day finish

The ‘Gut Health’ IHCAN Conference will finish at 16.30

This conference is sold out

This IHCAN Conference in collaboration with BANT is now completely sold out.

*To add yourself to the waiting list, click the button below.*

Add yourself to the waiting list

Book your place before it's too late...

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

Book your place